Pola Orbis Holdings Inc.

4927

JP3855900001

Personal Products

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-24 am EDT			5-day change	1st Jan Change
1,426 ^JPY	-0.73%		+3.30%	-10.01%

Mar. 22	Pola Orbis Holdings Inc Announces Executive Changes	CI
Feb. 14	Pola Orbis Holdings Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	CI

WELLPHARMA Inc. announced that it has received ¥150 million in funding from Pola Orbis Holdings Inc., MTG Ventures Co., Ltd., GeneQuest Inc. and other investors

May 08, 2022

WELLPHARMA Inc. announced that it has received ¥150 million in equity round of funding led by new investor Pola Orbis Holdings Inc. on May 9, 2022. The transaction included participation from MTG Ventures Co., Ltd., returning investor GeneQuest Inc. and other investors. The company has received funding through a third-party allotment of shares.

Latest news about Pola Orbis Holdings Inc.

Pola Orbis Holdings Inc Announces Executive Changes	Mar. 22	CI
Pola Orbis Holdings Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	Feb. 14	CI
Pola Orbis Holdings Inc. Announces Cash Dividend for the Fiscal Year Ended December 31, 2023, Payable on March 29, 2024; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal Year Ending December 31, 2024	Feb. 14	CI
Pola Orbis Plans New Subsidiary in China	Nov. 20	MT
Pola Orbis Holdings Inc. Establishes Overseas Subsidiary	Nov. 20	CI
Pola Orbis Holdings Inc. Announces Executive Changes as of January 1, 2024	Nov. 20	CI
Galapagos Co., Ltd. announced that it has received ¥1.111 billion in funding from a group of investors	Nov. 05	CI
Pola Orbis Holdings Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	23-10-30	CI
Pola Orbis Holdings Inc. Provides Dividend Guidance for the Year-End Fiscal Year 2023	23-10-30	CI
Pola Orbis Holdings' Creates New Subsidiary Pola Medical to Expand its Presence in Aesthetic Medicine Field	23-10-10	MT
Pola Orbis Holdings Inc. Announces Establishment of New Subsidiary	23-10-10	CI
Chai Inc. announced that it has received ¥170 million in funding from Toppan Inc., Pola Orbis Holdings Inc., SMBC Venture Capital Co., Ltd., THE SEED	23-08-08	CI
Pola Orbis Holdings Inc. Announces Second Quarter-End Dividend for the Six Months Ended June 30, 2023, Payable on September 8, 2023; Provides Year-End Dividend Guidance for the Fiscal Year Ending December 31, 2023	23-07-31	CI
Pola Orbis Holdings Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	23-07-31	CI
Pola Orbis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Pola Orbis Holdings Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	23-04-28	CI
Pola Orbis Holdings Inc. Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2023	23-04-28	CI
WBP Co., Ltd. announced that it has received funding from Okasan Capital Partners Co., Ltd., Pola Orbis Holdings Inc., Chatwork Co.,Ltd.	23-04-05	CI
LIFE CREATE Co., Ltd. announced that it has received ¥920 million in funding from Akatsuki Ventures, XTech Ventures Co., Ltd., Lotte Ventures Japan Co., Ltd., MTG Ventures Co., Ltd., Pola Orbis Holdings Inc.	23-03-27	CI
Japan Shares Add Profits on Easing South Korea Export Curbs; SoftBank's Arm to Target $8 Billion from US IPO in 2023	23-03-07	MT
Pola Orbis to Wind Up Two Cosmetic Brands	23-03-07	MT
Pola Orbis Records 3% Decline in FY22 Attributable Profit	23-02-16	MT
Pola Orbis Holdings Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	23-02-14	CI
Pola Orbis Holdings Inc. Announces Year End Cash Dividend for the Year Ended December 31, 2022, Payable from March 29, 2023; Provides Dividend Guidance for the Second Quarter of Fiscal Year 2023 and for the Fiscal Year Ending 2023	23-02-14	CI
Pola Orbis Holdings Announces Management Changes	22-12-01	CI

Chart Pola Orbis Holdings Inc.

Duration

Period

More charts

Company Profile

POLA ORBIS HOLDINGS INC. is a Japan-based holding company mainly engaged in the development, manufacture and sale of cosmetics. The Company operates through two business segments. The Beauty Care segment is engaged in the manufacture and sale of cosmetics, health foods, as well as sales of fashion items including ladies' underwear, women's clothing and jewelry. The brand includes POLA, ORBIS, ORLANE, DECENCIA, THREE, H2O, PLUS, Jurlique and other. The Real Estate segment is engaged in leasing of real estate properties, including office buildings and condominium. The other business is engaged in medical business and building maintenance business.

Sector

Personal Products

Calendar

2024-05-08 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Pola Orbis Holdings Inc.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

1,436 JPY

Average target price

1,584 JPY

Spread / Average Target

+10.29%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Personal Products

	1st Jan change	Capi.
POLA ORBIS HOLDINGS INC.	-10.01%	2.05B
PROCTER & GAMBLE COMPANY	+10.21%	381B
UNILEVER PLC	+1.94%	120B
COLGATE-PALMOLIVE COMPANY	+11.13%	72.81B
HINDUSTAN UNILEVER LIMITED	-15.18%	63.83B
ESTEE LAUDER	+1.83%	53.41B
KENVUE INC.	-10.15%	37.09B
BEIERSDORF	+2.76%	32.95B
ESSITY AB	+5.60%	17.08B
GODREJ CONSUMER PRODUCTS LIMITED	+7.21%	14.47B

Other Personal Products

Pola Orbis Holdings Inc.

Equities

4927

JP3855900001

Personal Products

WELLPHARMA Inc. announced that it has received ¥150 million in funding from Pola Orbis Holdings Inc., MTG Ventures Co., Ltd., GeneQuest Inc. and other investors

EPS Revisions